Correction to apoptin‐derived peptide reverses cisplatin resistance in gastric cancer through the PI3K–AKT signaling pathway.

The article titled "Correction to apoptin-derived peptide reverses cisplatin resistance in gastric cancer through the PI3K-AKT signaling pathway" published in Cancer Medicine in April 2018 contains corrections to several figures. The errors include the incorrect use of images and mislabeling of certain annotations. The corrected figures have been provided in the article. The authors apologize for these errors. [Extracted from the article]